A61K 39/0216
Bacteriodetes
Official title: {Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas}
A61K39/0216 (Bacteriodetes) appears on 80 US grants and 113 published applications in this corpus.
Search patents in A61K- Granted patents
- 80
- Published applications
- 113
- Assignees
- 84
- Inventors
- 180
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 2 |
| 2002 | 0 | 0 |
| 2003 | 4 | 1 |
| 2004 | 0 | 4 |
| 2005 | 2 | 3 |
| 2006 | 3 | 2 |
| 2007 | 1 | 0 |
| 2008 | 1 | 4 |
| 2009 | 1 | 3 |
| 2010 | 3 | 3 |
| 2011 | 1 | 6 |
| 2012 | 2 | 2 |
| 2013 | 2 | 6 |
| 2014 | 5 | 3 |
| 2015 | 1 | 3 |
| 2016 | 2 | 6 |
| 2017 | 2 | 5 |
| 2018 | 3 | 4 |
| 2019 | 2 | 8 |
| 2020 | 8 | 12 |
| 2021 | 8 | 9 |
| 2022 | 3 | 9 |
| 2023 | 6 | 4 |
| 2024 | 3 | 7 |
| 2025 | 3 | 4 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacterial strain with high cellulolytic activity26 May 2026US 12,636,322 B2Institut National Superieur Des Sciences Agronomiques De L'alimentation Et De L'environment
- CRA4S1 gene, encoded CRA4S1 protein, and application17 Feb 2026US 12,552,841 B2Zhenjiang Yangtze Green Biotechnology Co., Ltd.
- Delivery of bacteria-derived outer membrane vesicles20 Jan 2026US 12,527,852 B2Quadram Institute Bioscience
- Methods and compositions for treating inflammation21 Oct 2025US 12,448,419 B2UTI Limited Partnership
- Compositions and methods for inhibiting seizures22 Jul 2025US 12,364,717 B2The Regents of the University of California
- Porphyromonas gingivalis antigenic constructs3 Sep 2026US 2026/0256899 A1Sanofi
- Delivery of bacteria-derived outer membrane vesicles2 Jul 2026US 2026/0183376 A1Quadram Institute Bioscience
- Intranasal polysaccharide conjugate nanomulsion vaccines and methods of using the same8 Jan 2026US 2026/0007731 A1BlueWillow Biologics, Inc.
- Microbiota analogs of tumor associated antigens and uses thereof4 Dec 2025US 2025/0367276 A1Istituto Nazionale Tumori Irccs - Fondazione G. Pascale
- Bacterial strain with high cellulolytic activity16 Oct 2025US 2025/0319142 A1Institut National Superieur Des Sciences Agronomiques, De L'alimentation Et De L'environnement
Most cited
By later US patents
- Capsular polysaccharide immunomodulator51US 5,700,787 AThe Brigham and Women S Hospital, Inc. · 1997
- Compositions comprising bacterial strains46US 10,058,574 B24D Pharma Research Limited · 2018
- Use of zwitterionic polysaccharides for the specific modulation of immune processes41US 7,629,330 B2The Brigham and Women S Hospital, Inc. · 2009
- Capsular polysaccharide immunomodulator33US 5,679,654 AThe Brigham and Women S Hospital, Inc. · 1997
- Oral composition containing antibodies to Bacteroides gingivalis19US 4,689,221 ALion Corporation · 1987